Nick Pizzie Sells Shares and Options in Axsome Therapeutics, Inc.

On June 9, 2026, Nick Pizzie, Chief Financial Officer of Axsome Therapeutics, Inc. (AXSM), executed a series of transactions involving the company's common stock. Pizzie exercised stock options that were held for over 8 years, acquiring 33,000 shares at a price of $3.5 per share. These options were set to expire in 2028. Concurrently, Pizzie sold these 33,000 shares at a weighted average price of $240.09 per share, with individual sales prices ranging from $236.46 to $242.35. These sales were part of a pre-approved 10b5-1 plan that has now been completed. Following these transactions, Pizzie directly owns 42,867 shares and indirectly owns 488 shares, which are held as custodian for his children's UTMA accounts.